Literature DB >> 31373635

Trimethylamine N-Oxide Metabolites in Early Pregnancy and Risk of Gestational Diabetes: A Nested Case-Control Study.

Xiaoxu Huo1, Jing Li1, Yun-Feng Cao2,3, Sai-Nan Li4, Ping Shao5, Junhong Leng5, Weiqin Li5, Jinnan Liu1, Kai Yang4, Ronald C W Ma6, Gang Hu7, Zhong-Ze Fang4,8, Xilin Yang1,8.   

Abstract

OBJECTIVES: This study aimed to investigate the associations between trimethylamine N-oxide (TMAO) and related metabolites in early pregnancy and the risk of gestational diabetes mellitus (GDM).
DESIGN: A prospective cohort of 22,302 pregnant women from 2010 to 2012 in Tianjin, China, was used to perform a nested case-control study. A total of 243 women with GDM and 243 women without GDM matched by maternal age (±1 year) were used as cases and controls, respectively. Conditional logistic regression and restricted cubic spline were used to examine the full-range risk associations between individual TMAOs metabolites at the first antenatal care visit with GDM. Trimethylamine conversion ratio (TMAR) was defined as trimethylamine (TMA)/its precursors, and trimethylamine N-oxide conversion ratio (TMAOR) was defined as TMAO/TMA. An additive interaction between high TMAR and low TMAOR indicates a state of TMA accumulation, and a mathematical interaction between high TMAR and high TMAOR indicates accumulation of TMAO.
RESULTS: TMA was linearly associated with GDM, whereas TMA precursors and TMAO were inversely associated with GDM with clear threshold effects, i.e., 16 nmol/mL for TMAO, 200 nmol/mL for betaine, 112 nmol/mL for l-carnitine, and 110 and 270 nmol/mL for cholinechloride (a U-shaped relationship). Copresence of TMAR >0.35 and TMAOR ≤0.15 was associated with a markedly higher OR (11.16; 95% CI, 5.45 to 22.8), compared with TMAR >0.35 only (OR = 1.71; 95% CI, 0.42 to 6.95) or TMAOR ≤0.15 only (OR = 2.06; 95% CI, 1.09 to 3.90), with a significant additive interaction. However, the mathematical interaction was nonsignificant.
CONCLUSIONS: TMAO metabolites in the early pregnancy were associated with the risk of GDM, whereas TMA was more likely to play a causal role in GDM.
Copyright © 2019 Endocrine Society.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31373635      PMCID: PMC6779108          DOI: 10.1210/jc.2019-00710

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  40 in total

1.  Gut microbiota and intestinal FXR mediate the clinical benefits of metformin.

Authors:  Lulu Sun; Cen Xie; Guang Wang; Yue Wu; Qing Wu; Xuemei Wang; Jia Liu; Yangyang Deng; Jialin Xia; Bo Chen; Songyang Zhang; Chuyu Yun; Guan Lian; Xiujuan Zhang; Heng Zhang; William H Bisson; Jingmin Shi; Xiaoxia Gao; Pupu Ge; Cuihua Liu; Kristopher W Krausz; Robert G Nichols; Jingwei Cai; Bipin Rimal; Andrew D Patterson; Xian Wang; Frank J Gonzalez; Changtao Jiang
Journal:  Nat Med       Date:  2018-11-05       Impact factor: 53.440

2.  Causation and causal inference in epidemiology.

Authors:  Kenneth J Rothman; Sander Greenland
Journal:  Am J Public Health       Date:  2005       Impact factor: 9.308

3.  Metabolic profiling reveals a contribution of gut microbiota to fatty liver phenotype in insulin-resistant mice.

Authors:  Marc-Emmanuel Dumas; Richard H Barton; Ayo Toye; Olivier Cloarec; Christine Blancher; Alice Rothwell; Jane Fearnside; Roger Tatoud; Véronique Blanc; John C Lindon; Steve C Mitchell; Elaine Holmes; Mark I McCarthy; James Scott; Dominique Gauguier; Jeremy K Nicholson
Journal:  Proc Natl Acad Sci U S A       Date:  2006-08-08       Impact factor: 11.205

4.  A metagenome-wide association study of gut microbiota in type 2 diabetes.

Authors:  Junjie Qin; Yingrui Li; Zhiming Cai; Shenghui Li; Jianfeng Zhu; Fan Zhang; Suisha Liang; Wenwei Zhang; Yuanlin Guan; Dongqian Shen; Yangqing Peng; Dongya Zhang; Zhuye Jie; Wenxian Wu; Youwen Qin; Wenbin Xue; Junhua Li; Lingchuan Han; Donghui Lu; Peixian Wu; Yali Dai; Xiaojuan Sun; Zesong Li; Aifa Tang; Shilong Zhong; Xiaoping Li; Weineng Chen; Ran Xu; Mingbang Wang; Qiang Feng; Meihua Gong; Jing Yu; Yanyan Zhang; Ming Zhang; Torben Hansen; Gaston Sanchez; Jeroen Raes; Gwen Falony; Shujiro Okuda; Mathieu Almeida; Emmanuelle LeChatelier; Pierre Renault; Nicolas Pons; Jean-Michel Batto; Zhaoxi Zhang; Hua Chen; Ruifu Yang; Weimou Zheng; Songgang Li; Huanming Yang; Jian Wang; S Dusko Ehrlich; Rasmus Nielsen; Oluf Pedersen; Karsten Kristiansen; Jun Wang
Journal:  Nature       Date:  2012-09-26       Impact factor: 49.962

5.  Metabolic biomarkers of prenatal disorders: an exploratory NMR metabonomics study of second trimester maternal urine and blood plasma.

Authors:  Sílvia O Diaz; Joana Pinto; Gonçalo Graça; Iola F Duarte; António S Barros; Eulália Galhano; Cristina Pita; Maria do Céu Almeida; Brian J Goodfellow; Isabel M Carreira; Ana M Gil
Journal:  J Proteome Res       Date:  2011-06-30       Impact factor: 4.466

6.  Fetal one-carbon nutrient concentrations may be affected by gestational diabetes.

Authors:  Eran Barzilay; Ashley Moon; Lesley Plumptre; Shannon P Masih; Kyoung-Jin Sohn; Carly E Visentin; Anna Ly; Olga Malysheva; Ruth Croxford; Marie A Caudill; Deborah L O'Connor; Young-In Kim; Howard Berger
Journal:  Nutr Res       Date:  2018-04-21       Impact factor: 3.315

7.  Flavin containing monooxygenase 3 exerts broad effects on glucose and lipid metabolism and atherosclerosis.

Authors:  Diana M Shih; Zeneng Wang; Richard Lee; Yonghong Meng; Nam Che; Sarada Charugundla; Hannah Qi; Judy Wu; Calvin Pan; J Mark Brown; Thomas Vallim; Brian J Bennett; Mark Graham; Stanley L Hazen; Aldons J Lusis
Journal:  J Lipid Res       Date:  2014-11-06       Impact factor: 5.922

8.  Gestational diabetes mellitus in women of single gravidity in Tianjin City, China.

Authors:  Xilin Yang; Bridget Hsu-Hage; Hong Zhang; Lichun Yu; Ling Dong; Jingchun Li; Ping Shao; Changjun Zhang
Journal:  Diabetes Care       Date:  2002-05       Impact factor: 19.112

9.  Plasma concentration of trimethylamine-N-oxide and risk of gestational diabetes mellitus.

Authors:  Peiyun Li; Chunrong Zhong; Shuzhen Li; Taoping Sun; Hao Huang; Xi Chen; Yalun Zhu; Xiaoli Hu; Xiaobo Peng; Xu Zhang; Wei Bao; Zhilei Shan; Jinquan Cheng; Frank B Hu; Nianhong Yang; Liegang Liu
Journal:  Am J Clin Nutr       Date:  2018-09-01       Impact factor: 7.045

10.  Increased Trimethylamine N-Oxide Portends High Mortality Risk Independent of Glycemic Control in Patients with Type 2 Diabetes Mellitus.

Authors:  W H Wilson Tang; Zeneng Wang; Xinmin S Li; Yiying Fan; Daniel S Li; Yuping Wu; Stanley L Hazen
Journal:  Clin Chem       Date:  2016-11-18       Impact factor: 8.327

View more
  13 in total

Review 1.  Maternal and Fetal Metabolites in Gestational Diabetes Mellitus: A Narrative Review.

Authors:  Ionela Mihaela Vladu; Diana Clenciu; Adina Mitrea; Anca Amzolini; Simona Elena Micu; Anda Elena Crisan; Ion Cristian Efrem; Maria Fortofoiu; Mircea Catalin Fortofoiu; Adrian Mita; Anca Barau Alhija; Adina Dorina Glodeanu; Maria Mota
Journal:  Metabolites       Date:  2022-04-22

2.  Trimethylamine N-Oxide Metabolites in Early Pregnancy and Risk of Gestational Diabetes: A Nested Case-Control Study.

Authors:  Xiaoxu Huo; Jing Li; Yun-Feng Cao; Sai-Nan Li; Ping Shao; Junhong Leng; Weiqin Li; Jinnan Liu; Kai Yang; Ronald C W Ma; Gang Hu; Zhong-Ze Fang; Xilin Yang
Journal:  J Clin Endocrinol Metab       Date:  2019-11-01       Impact factor: 5.958

Review 3.  Gut microbiota-derived metabolite trimethylamine-N-oxide and multiple health outcomes: an umbrella review and updated meta-analysis.

Authors:  Doudou Li; Ying Lu; Shuai Yuan; Xiaxia Cai; Yuan He; Jie Chen; Qiong Wu; Di He; Aiping Fang; Yacong Bo; Peige Song; Debby Bogaert; Kostas Tsilidis; Susanna C Larsson; Huanling Yu; Huilian Zhu; Evropi Theodoratou; Yimin Zhu; Xue Li
Journal:  Am J Clin Nutr       Date:  2022-07-06       Impact factor: 8.472

4.  Acetylcarnitine Is Associated With Cardiovascular Disease Risk in Type 2 Diabetes Mellitus.

Authors:  Shuo Zhao; Ming-Li Liu; Bing Huang; Fu-Rong Zhao; Ying Li; Xue-Ting Cui; Rong Lin
Journal:  Front Endocrinol (Lausanne)       Date:  2021-12-14       Impact factor: 5.555

5.  Regulation of blood-brain barrier integrity by microbiome-associated methylamines and cognition by trimethylamine N-oxide.

Authors:  Lesley Hoyles; Matthew G Pontifex; Ildefonso Rodriguez-Ramiro; M Areeb Anis-Alavi; Khadija S Jelane; Tom Snelling; Egle Solito; Sonia Fonseca; Ana L Carvalho; Simon R Carding; Michael Müller; Robert C Glen; David Vauzour; Simon McArthur
Journal:  Microbiome       Date:  2021-11-27       Impact factor: 16.837

6.  U-Shaped Association Between Serum Uric Acid and Short-Term Mortality in Patients With Infective Endocarditis.

Authors:  Xuebiao Wei; Bingqi Fu; Xiaolan Chen; WeiTao Chen; Zhenqian Wang; Danqing Yu; Guozhi Jiang; Jiyan Chen
Journal:  Front Endocrinol (Lausanne)       Date:  2021-11-02       Impact factor: 5.555

7.  Dietary Protein Patterns during Pregnancy Are Associated with Risk of Gestational Diabetes Mellitus in Chinese Pregnant Women.

Authors:  Weijia Wu; Nu Tang; Jingjing Zeng; Jin Jing; Li Cai
Journal:  Nutrients       Date:  2022-04-13       Impact factor: 6.706

8.  Maternal Plasma Betaine in Middle Pregnancy Was Associated with Decreased Risk of GDM in Twin Pregnancy: A Cohort Study.

Authors:  Xiaoli Gong; Yufeng Du; Xiaona Li; Jing Yang; Xinyuan Zhang; Yuan Wei; Yangyu Zhao
Journal:  Diabetes Metab Syndr Obes       Date:  2021-06-03       Impact factor: 3.168

9.  The Alteration of Carnitine Metabolism in Second Trimester in GDM and a Nomogram for Predicting Macrosomia.

Authors:  Man Sun; Baihui Zhao; Sainan He; Ruopeng Weng; Binqiao Wang; Yunping Ding; Xinwen Huang; Qiong Luo
Journal:  J Diabetes Res       Date:  2020-08-11       Impact factor: 4.011

Review 10.  Trimethylamine N-Oxide in Relation to Cardiometabolic Health-Cause or Effect?

Authors:  Christopher Papandreou; Margret Moré; Aouatef Bellamine
Journal:  Nutrients       Date:  2020-05-07       Impact factor: 5.717

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.